Wound Care Plus, LLC Adopts the MolecuLight i:X as a Standard Point-of-Care Device for its Wound Care Service Offering to the Long-Term Care and Extended Care Markets i: X will Provide Essential Real-Time Information to Assist Wound Care Plus's Advanced Wound Care Consultants in Providing the Highest Quality Wound Care TORONTO and BLUE SPRINGS, Mo., Dec. 10, 2020 /PRNewswire/ -- MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing bacteria, announced that Wound Care Plus, LLC, the largest mobile wound care provider in the US Midwest, has adopted the MolecuLight i: X point-of-care imaging device to be included as part of its standard of care services offered to the long-term care and extended care markets.